JPH02204307A - Method for generating oxygen and oxygen generating agent - Google Patents

Method for generating oxygen and oxygen generating agent

Info

Publication number
JPH02204307A
JPH02204307A JP2355989A JP2355989A JPH02204307A JP H02204307 A JPH02204307 A JP H02204307A JP 2355989 A JP2355989 A JP 2355989A JP 2355989 A JP2355989 A JP 2355989A JP H02204307 A JPH02204307 A JP H02204307A
Authority
JP
Japan
Prior art keywords
oxygen
peroxide
tablet
tablets
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2355989A
Other languages
Japanese (ja)
Inventor
Takashi Imura
井村 尊
Hironaga Hayashi
林 裕修
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOMITA SEIYAKU KK
Tomita Pharmaceutical Co Ltd
Original Assignee
TOMITA SEIYAKU KK
Tomita Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOMITA SEIYAKU KK, Tomita Pharmaceutical Co Ltd filed Critical TOMITA SEIYAKU KK
Priority to JP2355989A priority Critical patent/JPH02204307A/en
Publication of JPH02204307A publication Critical patent/JPH02204307A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B13/00Oxygen; Ozone; Oxides or hydroxides in general
    • C01B13/02Preparation of oxygen
    • C01B13/0203Preparation of oxygen from inorganic compounds
    • C01B13/0211Peroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)

Abstract

PURPOSE:To simplify handling and to make it possible to regulate the rate of generation of oxygen and the duration time by disintegrating tablets contg. a peroxide and a disintegrating agent and tablets contg. a catalyst and a disintegrating agent in water to generate oxygen. CONSTITUTION:Tablets A contg. a peroxide such as calcium peroxide, barium peroxide or sodium peroxide and a disintegrating agent such as starch or talc are produced. Tablets B contg. a metallic salt catalyst such as manganese dioxide or manganese sulfate and a disintegrating agent are produced. The tablets A, B are disintigrated in water to bring the peroxide and the catalyst into a catalytic reaction. The rate of generation of oxygen and the duration time are regulated by changing the amt. of the disintegrating agent, tabletting pressure and additives when the tablets are produced.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、酸素の発生速度及び発生持続時間を調整する
酸素発生方法及び該方法に用いる酸素発生剤に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to an oxygen generating method for adjusting the rate and duration of oxygen generation, and an oxygen generating agent used in the method.

従来技術及びその問題点 火災発生の時の有毒ガスによる呼吸障害の緩和のような
緊急に酸素補給の必要がある場合には、ボンベ缶に圧入
された酸素ガスを吸入させる方法が専ら用いられている
。しかしながら、ガスボンベによる酸素吸入は、急激な
酸素の放出により人体へ悪影響をもたらすおそれがある
。また、ボンベ缶自体が重いため、携帯に不便である。
Prior art and its problems When there is an urgent need for oxygen supplementation, such as alleviating breathing problems caused by toxic gas in the event of a fire, a method of inhaling oxygen gas pressurized into a cylinder is exclusively used. There is. However, inhaling oxygen using a gas cylinder may have an adverse effect on the human body due to the sudden release of oxygen. Furthermore, the cylinder itself is heavy, making it inconvenient to carry.

従って、この方法に代わって、より手軽な酸素発生剤を
利用する酸素発生装置を用いる方法が現在注目されてい
る。
Therefore, instead of this method, a method using an oxygen generator that uses a simpler oxygen generating agent is currently attracting attention.

酸素発生剤は、例えば、水中で二酸化マンガン等の金属
塩の触媒下に下記に示す過酸化物の分解反応により酸素
を発生することを利用するものである。
The oxygen generating agent utilizes, for example, the generation of oxygen through the decomposition reaction of peroxide shown below under the catalyst of a metal salt such as manganese dioxide in water.

2Na2 CO3φ311202 2(Na2 COa   Ih O)+ 1120 +
1.502上記の反応は極めて急激に起こり、発熱反応
であるため、水温が急上昇し、これに伴って、酸素及び
水蒸気の発生による突沸現象等を生ずる。しかも、反応
は短時間で終結して、酸素の発生は終了する。
2Na2 CO3φ311202 2(Na2 COa Ih O) + 1120 +
1.502 Since the above reaction occurs extremely rapidly and is an exothermic reaction, the water temperature rises rapidly, and along with this, a bumping phenomenon occurs due to the generation of oxygen and water vapor. Moreover, the reaction ends in a short time and the generation of oxygen ends.

例えば、現在市販されている粉末状又は顆粒状の酸素発
生剤は、反応を30〜180秒程度で終了してしまい、
しかも、剤型の性質上、組成が劣化し易く、使用時に粉
塵が発生する等の取り扱い上の問題をも有する。
For example, with the powdered or granular oxygen generating agents currently on the market, the reaction completes in about 30 to 180 seconds;
Furthermore, due to the nature of the dosage form, the composition tends to deteriorate and there are problems in handling, such as generation of dust during use.

この様な問題を解決するために、急激な酸素の発生を抑
制し、酸素の発生速度及び発生持続時間を容易にコント
ロールすることができる酸素発生剤が研究されている。
In order to solve these problems, research has been carried out on oxygen generating agents that can suppress rapid oxygen generation and easily control the rate and duration of oxygen generation.

例えば、特公昭6〇−44242は、炭酸ナトリウムと
過酸化水素との付加化合物の結晶性粉末と濃度の異なる
アラビア糊で固化された金属塩の球状固形物とからなる
酸素発生剤を提案している。しかしながら、この酸素発
生剤は、触媒を水溶性糊剤で固結したものと過酸化物の
粉末とを混ぜたものにすぎないので、保存安定性が悪く
、取扱いが困難である、酸素の発生を十分にコントロー
ルし得るとはいい難い等の欠点を有する。
For example, Japanese Patent Publication No. 60-44242 proposed an oxygen generating agent consisting of a crystalline powder of an addition compound of sodium carbonate and hydrogen peroxide and a spherical solid of a metal salt solidified with Arabic glue of different concentrations. There is. However, this oxygen generating agent is simply a mixture of a catalyst solidified with a water-soluble glue and peroxide powder, so it has poor storage stability and is difficult to handle. It has drawbacks such as the fact that it cannot be said that it can be controlled sufficiently.

問題点を解決するための手段 本発明者は、上記のような従来の酸素発生剤の持つ欠点
を改良すべく鋭意研究を行なった結果、過酸化物及び触
媒をそれぞれ崩壊剤を用いて別個に錠剤化するとともに
、過酸化物及び崩壊剤を含有する錠剤並びに触媒及び崩
壊剤を含有する錠剤を製造するに際し、錠剤の硬度を変
化させることにより、酸素の発生速度及び発生持続時間
をコントロールすることが可能となることを見出だした
Means for Solving the Problems The present inventor conducted extensive research to improve the drawbacks of conventional oxygen generating agents as described above, and as a result, the inventor developed a method to separate peroxides and catalysts using disintegrants. To control the rate and duration of oxygen generation by changing the hardness of the tablet when tabletting and manufacturing tablets containing peroxide and a disintegrant, and tablets containing a catalyst and a disintegrant. We have discovered that this is possible.

即ち、本発明は、 a)過酸化物と金属塩とを反応させて酸素を発生させる
方法において、過酸化物及び崩壊剤を含む錠剤と触媒及
び崩壊剤を含む錠剤とを水中で崩壊させて、錠剤の内容
物を反応させることにより、酸素の発生速度及び発生時
間を調整することを特徴とする方法、及び b)過酸化物及び崩壊剤を含有する錠剤Aと金属塩及び
崩壊剤を含有する錠剤Bとからなる酸素発生剤 を提供する。
That is, the present invention provides a) a method for generating oxygen by reacting a peroxide and a metal salt, which comprises disintegrating a tablet containing a peroxide and a disintegrant and a tablet containing a catalyst and a disintegrant in water. , a method characterized by adjusting the oxygen generation rate and generation time by reacting the contents of the tablet, and b) a tablet A containing a peroxide and a disintegrant, and a metal salt and a disintegrant. Provided is an oxygen generating agent comprising a tablet B.

本発明では、過酸化物及び触媒をそれぞれ別個の錠剤と
することが必要である。過酸化物と金属塩の両成分を含
有する錠剤は、両成分が錠剤中で反応するために、保存
安定性が低下したり、場合によっては、爆発の危険性を
生ずる等の短所があり、好ましい結果が得られない。
The present invention requires that the peroxide and catalyst be each in separate tablets. Tablets containing both peroxide and metal salt have disadvantages such as decreased storage stability and, in some cases, a risk of explosion, as both components react in the tablet. Favorable results are not obtained.

本発明で用いる過酸化物としては、常温で固体のもので
あり、公知の酸素発生剤において使用されているものを
、用いることができる。例えば、炭酸ナトリウムと過酸
化水素との付加物、炭酸カリウムと過酸化水素との付加
物、酸化カルシウムと過酸化水素との付加物等の過酸化
水素付加物、過酸化カルシウム、過酸化カルシウム、過
酸化バリウム、過酸化亜鉛、過酸化ナトリウム、過酸化
カリウム等の金属過酸化物、過マンガン酸カリウム、重
クロム酸ナトリウム、過ホウ酸ナトリウム等が挙げられ
る。
As the peroxide used in the present invention, those that are solid at room temperature and are used in known oxygen generating agents can be used. For example, hydrogen peroxide adducts such as adducts of sodium carbonate and hydrogen peroxide, adducts of potassium carbonate and hydrogen peroxide, adducts of calcium oxide and hydrogen peroxide, calcium peroxide, calcium peroxide, Examples include metal peroxides such as barium peroxide, zinc peroxide, sodium peroxide, and potassium peroxide, potassium permanganate, sodium dichromate, and sodium perborate.

触媒として用いる金属塩としては、二酸化マンガン、硫
酸マンガン、酸化鉄、硫酸鉄、酸化鉛、酸化銅等を用い
ることができる。
As the metal salt used as a catalyst, manganese dioxide, manganese sulfate, iron oxide, iron sulfate, lead oxide, copper oxide, etc. can be used.

本発明の酸素発生剤では、水中における過酸化物と金属
塩との急激な反応を抑制し、酸素の発生をコントロール
するために、崩壊剤を使用する。
In the oxygen generating agent of the present invention, a disintegrant is used in order to suppress the rapid reaction between peroxide and metal salt in water and control the generation of oxygen.

崩壊剤は、保存時の吸湿による安定性低下を防止し、且
つ水中で錠剤を所定の速度で崩壊させるために、耐湿性
ではあるが、大量の水との接触下に水中に分散し得るの
ものである必要がある。例えば、デンプン、寒天束、メ
チルセルロース、ヒドロキシプロピルセルロース、繊維
素グリコール酸カルシウム、繊維素グリコール酸ナトリ
ウム、結晶セルロース等を挙げることができる。これら
の内、好ましいものは、結晶セルロース、繊維素グリコ
ール酸ナトリウム及び繊維素グリコール酸カルシウムで
あり、特に好ましいものは、繊維素グリコール酸カルシ
ウムである。
Disintegrants are moisture-resistant but can be dispersed in water when in contact with a large amount of water, in order to prevent stability deterioration due to moisture absorption during storage and to disintegrate tablets in water at a predetermined rate. It needs to be something. Examples include starch, agar bundles, methyl cellulose, hydroxypropyl cellulose, calcium cellulose glycolate, sodium cellulose glycolate, and crystalline cellulose. Among these, preferred are crystalline cellulose, sodium cellulose glycolate, and calcium cellulose glycolate, and particularly preferred is calcium cellulose glycolate.

本発明において、酸素発生剤は、本発明の効果に影響し
ない限り、崩壊剤以外の添加剤を含有していてよい。例
えば、打錠機の臼や杵から錠剤の離れをよくし、錠剤の
光沢を増すための滑沢剤、錠剤の成分に結合力を与えて
、崩壊性をより精密に調整するための結合剤等を含有す
ることができる。特に、長時間の酸素発生を行う場合に
は、結合剤を加えて調製することが好ましい。特に制限
されるものではないが、滑沢剤としては、タルク、アジ
ピン酸等、結合剤としては、ポリエチレングリコール、
メチルセルロース等が挙げられる本発明酸素発生剤にお
いては、過酸化物及び崩壊剤を含む錠剤を錠剤Aとし、
触媒及び崩壊剤を含む錠剤を錠剤Bとする。
In the present invention, the oxygen generating agent may contain additives other than the disintegrant as long as they do not affect the effects of the present invention. For example, a lubricant that helps tablets separate from the die or punch of a tablet machine and increases the gloss of the tablet, and a binder that provides binding strength to tablet components to more precisely adjust disintegration properties. etc. can be contained. In particular, when oxygen generation is performed for a long period of time, it is preferable to add a binder to the preparation. Although not particularly limited, examples of lubricants include talc and adipic acid, and examples of binders include polyethylene glycol,
In the oxygen generating agent of the present invention, which includes methylcellulose, a tablet containing a peroxide and a disintegrant is referred to as a tablet A,
The tablet containing the catalyst and disintegrant is referred to as Tablet B.

錠剤Aにおいて、崩壊剤の使用量は、過酸化物100重
量部に対して、0.1〜6重曾部程度、好ましくは、3
〜5重量部程度とする。0.1重量部未満では、崩壊性
が悪いため、望ましい酸素発生量が得られず、6重量部
を超えると、水中での錠剤の崩壊が早いため、急激な酸
素の発生が起こる。
In tablet A, the amount of disintegrant used is about 0.1 to 6 parts by weight, preferably 3 parts by weight, per 100 parts by weight of peroxide.
~5 parts by weight. If it is less than 0.1 part by weight, disintegration is poor and the desired amount of oxygen generated cannot be obtained, and if it exceeds 6 parts by weight, the tablet disintegrates quickly in water, resulting in rapid oxygen generation.

錠剤Bにおいて、崩壊剤の使用量は、過酸化物100重
伝部に対して、0.1〜6重量部程度、好ましくは、1
〜3重量部程度とする。0.1重量部未満では、崩壊性
が悪いため、酸素発生の量的及び時間的コントロールが
しにくく、6重量部を超えると、触媒を早急に放出する
ため、酸素及び水蒸気の発生による突沸現象が生ずる。
In tablet B, the amount of disintegrant used is about 0.1 to 6 parts by weight, preferably 1 part by weight, per 100 parts by weight of peroxide.
~3 parts by weight. If it is less than 0.1 parts by weight, the disintegration is poor, making it difficult to control the amount and time of oxygen generation. If it exceeds 6 parts by weight, the catalyst will be released quickly, resulting in bumping phenomenon due to the generation of oxygen and water vapor. occurs.

錠剤Aに対する錠剤Bの使用割合は、過酸化物の量に対
する触媒の量で算出する。一般に、過酸化物100重量
部に対して、触媒1〜10重量部程度、好ましくは、4
〜6重量部程度用いる。1重量部未満では、触媒効果が
得られないため、望ましい酸素発生量が得られない。1
0重量部を超えると、反応速度が早くなるため、酸素発
生持続効果が低下する。
The usage ratio of tablet B to tablet A is calculated based on the amount of catalyst relative to the amount of peroxide. Generally, about 1 to 10 parts by weight of catalyst, preferably 4 parts by weight, per 100 parts by weight of peroxide.
~6 parts by weight is used. If it is less than 1 part by weight, no catalytic effect can be obtained, and therefore the desired amount of oxygen generated cannot be obtained. 1
If it exceeds 0 parts by weight, the reaction rate becomes faster and the effect of sustaining oxygen generation decreases.

錠剤A及びBの製法は、通常の圧縮錠剤化法により、粉
末状の錠剤成分を圧縮することにより、実施される。
Tablets A and B are manufactured by compressing powdered tablet components using a conventional compression tableting method.

錠剤の大きさは、錠剤Aは直径20〜50mm程度、厚
さ10〜20+a程度とし、錠剤Bは直径5〜20a+
m程度、厚さ1〜5mm程度とする。
Tablet A has a diameter of about 20 to 50 mm and a thickness of about 10 to 20 mm, and tablet B has a diameter of 5 to 20 mm.
The thickness should be approximately 1 to 5 mm.

錠剤の硬度は、錠剤A及び錠剤Bともに5kg〜30k
g(直径5+mの針を使用した場合)である。
The hardness of the tablets is 5kg to 30k for both tablets A and B.
g (when using a needle with a diameter of 5+m).

5kg未満の場合、錠剤の崩壊性が高くなるために、急
激に酸素が発生し、30kgを上まわると、望ましい崩
壊性が低下するため、所望の酸素発生量を得ることがで
きない。両錠剤の硬度は、短時間内に比較的多量の酸素
発生を目的とする場合、或いは比較的少口だが持続的な
酸素発生を目的とする場合などに応じて、上記の範囲で
適宜選択すれば良い。
When the weight is less than 5 kg, the disintegration of the tablet becomes high, and oxygen is rapidly generated. When the weight exceeds 30 kg, the desired disintegration property decreases, making it impossible to obtain the desired amount of oxygen generated. The hardness of both tablets should be selected as appropriate within the above range depending on whether the purpose is to generate a relatively large amount of oxygen in a short period of time, or if the purpose is to generate a relatively small amount of oxygen continuously. Good.

上記の硬度を得るための打錠圧力は、錠剤の大きさによ
って変化し、例えば、錠剤が直径的45mm、厚さ約1
9mmの大きさである場合、100〜500 kg/ 
cm2程度である。
The tableting pressure to obtain the above hardness varies depending on the size of the tablet. For example, the tablet has a diameter of 45 mm and a thickness of about 1 mm.
If the size is 9mm, 100-500 kg/
It is about cm2.

本発明酸素発生剤は、救急時や肺性疾患における人体へ
の適用以外にも、種子の発芽、魚の養殖、活魚、青果物
、植物等の鮮度保持、土壌の改良等の酸素補給を必要と
する種々の用途に広く用いることができる。
In addition to being applied to the human body in emergencies and pulmonary diseases, the oxygen generating agent of the present invention is also useful for seed germination, fish farming, maintaining the freshness of live fish, fruits and vegetables, plants, etc., and soil improvement, which require oxygen supplementation. It can be widely used for various purposes.

発明の効果 本発明によれば、下記のような効果が得られる。Effect of the invention According to the present invention, the following effects can be obtained.

(1)従来の酸素発生剤に比較して、取り扱いが簡単で
、粉末や顆粒剤の様な飛散性が無い酸素発生剤を得るこ
とができる。
(1) Compared to conventional oxygen generating agents, it is possible to obtain an oxygen generating agent that is easier to handle and has no scattering properties like powder or granules.

(2)酸素発生剤の製造時において、崩壊剤の量、打錠
圧力及び添加剤を変えることにより、酸素発主速度、酸
素発生持続時間等を目的に合わせ、容易にコントロール
できる。
(2) During the production of the oxygen generating agent, by changing the amount of disintegrant, tableting pressure, and additives, the oxygen generation rate, oxygen generation duration, etc. can be easily controlled according to the purpose.

(3)製法が簡単で、多口的の商品化が容易である。(3) The manufacturing method is simple, and multi-portion commercialization is easy.

(4)長期保存において製品劣化しにくい製剤を得るこ
とができる。
(4) It is possible to obtain a formulation that does not easily deteriorate during long-term storage.

実施例 以下に実施例及び比較例を示し、本発明を更に詳しく説
明する。
EXAMPLES The present invention will be explained in more detail with reference to Examples and Comparative Examples below.

実施例1 (1)炭酸ナトリウムと過酸化水素との付加物94重量
部、タルク1重量部及び繊維素グリコール酸カルシウム
5重量部を混合した。混合物40gを打錠圧力100又
は500kg/cdで、直径45龍の基石状円形錠剤に
成形した(7A−8M、5打錠機(菊水製作所製)を用
いた)。得られた2種類の錠剤(それぞれ“錠剤A1″
及び“錠剤A2”とする)の厚さ及び硬度を測定した。
Example 1 (1) 94 parts by weight of an adduct of sodium carbonate and hydrogen peroxide, 1 part by weight of talc, and 5 parts by weight of cellulose calcium glycolate were mixed. 40 g of the mixture was molded into a base stone-shaped circular tablet with a diameter of 45 mm at a tableting pressure of 100 or 500 kg/cd (using a 7A-8M, 5 tablet press (manufactured by Kikusui Seisakusho)). The two types of tablets obtained (each “Tablet A1”)
and "Tablet A2") were measured for thickness and hardness.

厚 さ  硬度   打鍵圧力 (++im)   (kg)    (kg/cm2)
錠剤Al   20    9   100錠剤A2 
 18   28   500※ 硬度の測定は、硬度
計(本屋製作所製)を使用し、加圧針の直径を5mmと
した。
Thickness Hardness Key pressure (++im) (kg) (kg/cm2)
Tablet Al 20 9 100 Tablet A2
18 28 500 * The hardness was measured using a hardness meter (manufactured by Honya Seisakusho), and the diameter of the pressure needle was 5 mm.

(2)二酸化マンガン94重量部、繊維素グリコール酸
カルシウム3重量部、ポリエチレングリコール2重量部
及びアジピン酸1重量部を混合した。
(2) 94 parts by weight of manganese dioxide, 3 parts by weight of cellulose calcium glycolate, 2 parts by weight of polyethylene glycol, and 1 part by weight of adipic acid were mixed.

混合物1gを直径111m、厚さ3m−の基石状円形錠
剤に打錠した(錠剤Bl)。そのときの打錠圧力は20
00 kg/ cra2であり、得られた錠剤硬度は8
kgであった。
1 g of the mixture was compressed into stone-shaped circular tablets with a diameter of 111 m and a thickness of 3 m (Tablet B1). The tableting pressure at that time was 20
00 kg/cra2, and the obtained tablet hardness was 8
It was kg.

上記(1)で得られた錠剤A1又はA2を1錠、(2)
で得られた錠剤B1を3錠取り、これらを水8001+
112(水温25℃)中に加え、発生する酸素量(1/
分)を測定した。
1 tablet of A1 or A2 obtained in (1) above, (2)
Take 3 tablets of B1 obtained in step 1 and add them to water 8001+
112 (water temperature 25℃) and the amount of oxygen generated (1/
minutes) was measured.

結果を第1表及び第1図に示す。The results are shown in Table 1 and Figure 1.

第1表Table 1

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、本発明錠剤を水中で反応させた時の時間(分
)に対する酸素発生量を示す。 (以 上) 第1表に示す結果から、本発明によれば、錠剤の硬度を
変化させることにより、酸素発生状態を調整できること
が明らかである。 手続辛市正書岨発) 平成1年2月17日 特許庁長官 吉 1)文 毅 殿 事件との関係  特許出願人 富田製薬株式会社
FIG. 1 shows the amount of oxygen generated versus time (minutes) when the tablet of the present invention was reacted in water. (Above) From the results shown in Table 1, it is clear that according to the present invention, the oxygen generation state can be adjusted by changing the hardness of the tablet. February 17, 1999 Director General of the Patent Office Yoshi 1) Relationship with the Moon Yi case Patent applicant Tomita Pharmaceutical Co., Ltd.

Claims (2)

【特許請求の範囲】[Claims] (1)過酸化物と触媒とを反応させて酸素を発生させる
法において、過酸化物及び崩壊剤を含む錠剤と触媒及び
崩壊剤を含む錠剤とを水中で崩壊させて、過酸化物と触
媒とを接触反応させることにより、酸素の発生速度及び
発生持続時間を調整することを特徴とする方法。
(1) In a method of reacting peroxide and a catalyst to generate oxygen, a tablet containing a peroxide and a disintegrant and a tablet containing a catalyst and a disintegrant are disintegrated in water, and the peroxide and the catalyst are disintegrated. A method characterized by adjusting the rate and duration of oxygen generation by causing a contact reaction with.
(2)過酸化物及び崩壊剤を含有する錠剤Aと金属塩及
び崩壊剤を含有する錠剤Bとからなる酸素発生剤。
(2) An oxygen generating agent consisting of tablet A containing a peroxide and a disintegrant and tablet B containing a metal salt and a disintegrant.
JP2355989A 1989-01-31 1989-01-31 Method for generating oxygen and oxygen generating agent Pending JPH02204307A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2355989A JPH02204307A (en) 1989-01-31 1989-01-31 Method for generating oxygen and oxygen generating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2355989A JPH02204307A (en) 1989-01-31 1989-01-31 Method for generating oxygen and oxygen generating agent

Publications (1)

Publication Number Publication Date
JPH02204307A true JPH02204307A (en) 1990-08-14

Family

ID=12113872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2355989A Pending JPH02204307A (en) 1989-01-31 1989-01-31 Method for generating oxygen and oxygen generating agent

Country Status (1)

Country Link
JP (1) JPH02204307A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006001607A1 (en) * 2004-06-23 2006-01-05 J. C. Technologies, Inc. Oxygen generating composition
JP2007513042A (en) * 2003-11-20 2007-05-24 オキシシュア システムズ,インク. Method and apparatus for generating oxygen
CN112674001A (en) * 2020-12-21 2021-04-20 中国药科大学 Composite tablet with function of slowly releasing oxygen, preparation method and application
US12304810B2 (en) 2021-05-21 2025-05-20 Sensirion Ag Gas generator

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57160902A (en) * 1981-03-28 1982-10-04 Yoshinori Seiji Generating method for oxygen with sodium percarbonate in emergency
JPS6185969A (en) * 1984-10-03 1986-05-01 株式会社 柏化学工業 Simple generation of breathing oxygen gas
JPS62270407A (en) * 1986-05-15 1987-11-24 Shiraishi Chuo Kenkyusho:Kk Oxygen generator

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57160902A (en) * 1981-03-28 1982-10-04 Yoshinori Seiji Generating method for oxygen with sodium percarbonate in emergency
JPS6185969A (en) * 1984-10-03 1986-05-01 株式会社 柏化学工業 Simple generation of breathing oxygen gas
JPS62270407A (en) * 1986-05-15 1987-11-24 Shiraishi Chuo Kenkyusho:Kk Oxygen generator

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513042A (en) * 2003-11-20 2007-05-24 オキシシュア システムズ,インク. Method and apparatus for generating oxygen
WO2006001607A1 (en) * 2004-06-23 2006-01-05 J. C. Technologies, Inc. Oxygen generating composition
CN112674001A (en) * 2020-12-21 2021-04-20 中国药科大学 Composite tablet with function of slowly releasing oxygen, preparation method and application
US12304810B2 (en) 2021-05-21 2025-05-20 Sensirion Ag Gas generator

Similar Documents

Publication Publication Date Title
US4265847A (en) Tabletting process
US4104190A (en) Generation of chlorine dioxide for disinfection and sterilization
EP2038213B1 (en) Stabilized composition for producing chlorine dioxide
US4414198A (en) Rapidly disintegrable tablet composition and method
US5256699A (en) Dispersible tablet formulation of diclofenac acid free base
US5104648A (en) High ibuprofen content granulations
RU2111663C1 (en) Solid friable composition of carrier for active substance in solid dosed water-dispersible form, method for producing it and solid dosed medicinal form
MXPA02007468A (en) Massive bodies for producing highly converted solutions of chlorine dioxide.
SA94150373B1 (en) Paroxetine tablets and a process for its preparation
JP2012001557A (en) Improved fast disintegrating tablet
KR920005979A (en) Pharmaceutical composition with excellent taste containing porous particles and method for preparing the pharmaceutical composition
CA2009326C (en) Aqueous granulation solution and a method of tablet granulation
IE62557B1 (en) Dispersible Formulation
US3976601A (en) Water soluble lubricant for tabletting compositions
MX2010014503A (en) Orodispersible mannitol.
JPH02204307A (en) Method for generating oxygen and oxygen generating agent
US4536389A (en) Bactericidal tabletting composition and tablets formed therefrom
US5846564A (en) Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
EP0237241A2 (en) Calcium supplement compressed tablets
CA2258917A1 (en) Disintegrant composition for dispersible solids
EP0367056A2 (en) A granulating composition and method
JPS58161904A (en) Composition for slowly generating gaseous chlorine dioxide
CA2329046C (en) Composition comprising l-ascorbic acid and pectin
JP2005154232A (en) Hydrogen storage material and hydrogen producing method
JPS6177605A (en) Oxygen generating pellet